Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Marina Hincapie"'
Publikováno v:
Bioanalysis. 6:2537-2548
Aim: Current analytical tools lack the required capacity to reduce the complexity of the plasma proteome and identify low-level proteins of clinical interest. Hence, the need to develop a fractionation approach to provide adequate throughput for a cl
Autor:
Mathias Uhlén, Seul Ki Jeong, William S. Hancock, Samir M. Hanash, Chris Gates, Hoguen Kim, Hogune Im, Shiaw-Lin Wu, Marina Hincapie, Zhaomei Mu, Edouard C. Nice, Pascale Gaudet, Massimo Cristofanilli, David Fenyö, Rui Chen, Amos Marc Bairoch, George I. Mias, Michael Snyder, Fangfei Yan, Young-Ki Paik, Ronald C. Beavis, Emma Lundberg, Suli Liu, Yue Zhang, Susan Fanayan, Gilbert S. Omenn, Lance Wells, Stephen Dalton, Fan Zhang, Eric W. Deutsch, Rajasree Menon
Publikováno v:
Journal of Proteome Research, Vol. 12, No 1 (2013) pp. 45-57
Journal of Proteome Research; Vol 12
Journal of Proteome Research; Vol 12
We report progress assembling the parts list for chromosome 17 and illustrate the various processes that we have developed to integrate available data from diverse genomic and proteomic knowledge bases. As primary resources, we have used GPMDB, neXtP
Autor:
Susan Fanayan, Ling Y. Lee, Mark S. Baker, William S. Hancock, Marina Hincapie, Nicolle H. Packer
Publikováno v:
Journal of Separation Science. 35:2445-2452
Lectins are capable of recognizing specific glycan structures and serve as invaluable tools for the separation of glycosylated proteins from nonglycosylated proteins in biological samples. We report on the optimization of native multi-lectin affinity
Publikováno v:
Journal of Chromatography A. 1256:121-128
Identification of potential changes in the glycosylation of existing cancer biomarkers can result in a higher level of diagnostic sensitivity and specificity. Clusterin (Apolipoprotein J) has been implicated in renal cell carcinoma (RCC) and other ty
Publikováno v:
Biotechnology and Bioengineering. 109:3007-3017
Within the biotechnology industry there is a continuous drive to better and more fully understand the biopharmaceutical process in order to achieve better process control. A method to monitor and quantitate glycomic changes that occur in CHO cells du
Publikováno v:
ELECTROPHORESIS. 33:1746-1754
Aberrant protein glycosylation has been shown to be associated with disease processes and identification of disease-specific glycoproteins and glycosylation changes may serve as potential diagnostic and therapeutic biomarkers. However despite recent
Publikováno v:
Analytical and Bioanalytical Chemistry. 402:2687-2700
The development of a general method for the purification and quantitative glycomic analysis of human plasma samples to characterize global glycosylation changes shall be presented. The method involves multiple steps, including the depletion of plasma
Publikováno v:
Journal of Proteome Research. 11:808-817
Protein biomarkers are critical for diagnosis, prognosis, and treatment of disease. The transition from protein biomarker discovery to verification can be a rate limiting step in clinical development of new diagnostics. Liquid chromatography-selected
Publikováno v:
Analytical Chemistry. 83:2029-2037
Site-specific analysis of protein glycosylation is important for biochemical and clinical research efforts. Glycopeptide analysis using liquid chromatography−collision-induced dissociation/electron transfer dissociation mass spectrometry (LC−CID/
Publikováno v:
Anal. Methods. 3:20-32
Several approaches and technologies are currently available to study the glycosylated proteome (glycoproteomics) or the entire repertoire of glycans in a biological system (glycomics). The biological importance of glycosylation has driven the develop